JP2023549126A5 - - Google Patents
Info
- Publication number
- JP2023549126A5 JP2023549126A5 JP2023527357A JP2023527357A JP2023549126A5 JP 2023549126 A5 JP2023549126 A5 JP 2023549126A5 JP 2023527357 A JP2023527357 A JP 2023527357A JP 2023527357 A JP2023527357 A JP 2023527357A JP 2023549126 A5 JP2023549126 A5 JP 2023549126A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- approximately
- present
- seq
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063111367P | 2020-11-09 | 2020-11-09 | |
| US63/111,367 | 2020-11-09 | ||
| PCT/US2021/057802 WO2022098682A1 (en) | 2020-11-09 | 2021-11-03 | Peptide formulations and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549126A JP2023549126A (ja) | 2023-11-22 |
| JP2023549126A5 true JP2023549126A5 (https=) | 2024-11-12 |
Family
ID=81457409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527357A Pending JP2023549126A (ja) | 2020-11-09 | 2021-11-03 | ペプチド製剤および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230414506A1 (https=) |
| EP (1) | EP4240392A4 (https=) |
| JP (1) | JP2023549126A (https=) |
| KR (1) | KR20230106643A (https=) |
| CN (1) | CN116437938A (https=) |
| AU (1) | AU2021376124A1 (https=) |
| CA (1) | CA3194447A1 (https=) |
| IL (1) | IL302567A (https=) |
| MX (1) | MX2023005395A (https=) |
| WO (1) | WO2022098682A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022094372A1 (en) * | 2020-11-02 | 2022-05-05 | Realta Life Sciences, Inc. | Peptides and methods of use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008013955A2 (en) * | 2006-07-27 | 2008-01-31 | Nektar Therapeutics | Sustained release formulations for pulmonary delivery |
| PT2432489T (pt) * | 2009-05-20 | 2016-12-07 | Biomarin Pharm Inc | Variantes do péptido natriurético de tipo c |
| SG11201510732VA (en) * | 2013-07-26 | 2016-01-28 | Sanofi Sa | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| ES2875498T3 (es) * | 2015-06-26 | 2021-11-10 | Realta Holdings Llc | Compuestos de péptidos sintéticos y procedimientos de uso |
| WO2017093810A2 (en) * | 2015-10-14 | 2017-06-08 | Pharcon Inc. | Composition for intraoral delivery of biologically active peptides and proteins |
| US12018054B2 (en) * | 2017-04-13 | 2024-06-25 | Valneva Austria Gmbh | Multivalent OspA polypeptides and methods and uses relating thereto |
| EP3740074B1 (en) * | 2018-01-09 | 2024-11-06 | ReAlta Holdings, LLC | Pic1 inhibition of myeloperoxidase oxidative activity in an animal model |
| US12441776B2 (en) * | 2018-11-30 | 2025-10-14 | Eirgen Pharma Ltd. | Oxyntomodulin peptide analog formulations |
| WO2020243220A1 (en) * | 2019-05-28 | 2020-12-03 | Realta Holdings, Llc | Pic1 peptide compositions and methods of use thereof for treatment of hypoxic ischemic encephalopathy |
-
2021
- 2021-11-03 CA CA3194447A patent/CA3194447A1/en active Pending
- 2021-11-03 EP EP21889935.9A patent/EP4240392A4/en active Pending
- 2021-11-03 IL IL302567A patent/IL302567A/en unknown
- 2021-11-03 KR KR1020237018965A patent/KR20230106643A/ko active Pending
- 2021-11-03 MX MX2023005395A patent/MX2023005395A/es unknown
- 2021-11-03 CN CN202180072873.1A patent/CN116437938A/zh active Pending
- 2021-11-03 AU AU2021376124A patent/AU2021376124A1/en active Pending
- 2021-11-03 US US18/035,846 patent/US20230414506A1/en active Pending
- 2021-11-03 WO PCT/US2021/057802 patent/WO2022098682A1/en not_active Ceased
- 2021-11-03 JP JP2023527357A patent/JP2023549126A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2546378T3 (es) | Moduladores de propiedades farmacocinéticas de agentes terapéuticos | |
| JP2023082213A (ja) | Ｎ４－ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 | |
| TWI798593B (zh) | 法匹拉韋在治療冠狀病毒感染方面的應用 | |
| ES2602784T3 (es) | Moduladores de las propiedades farmacocinéticas de los agentes terapéuticos | |
| JP2023002662A5 (https=) | ||
| JP2002519318A5 (https=) | ||
| JP2024170583A5 (https=) | ||
| JP2007246536A (ja) | １−（２−（ヒドロキシメチル）−１，３−オキサチオラン−５−イル）−５−フルオロシトシンのｂ型肝炎治療への使用 | |
| US20230159516A1 (en) | Compounds for the treatment of sars | |
| JP2009521473A5 (https=) | ||
| CN113164505A (zh) | 用于治疗丙型肝炎病毒的高活性药物组合 | |
| CA2991156A1 (en) | Compositions and methods for the treatment of viral infection | |
| JP2023549126A5 (https=) | ||
| JP2024504225A5 (https=) | ||
| CN111320625A (zh) | 一种治疗肺炎的化合物及其应用 | |
| JP2022527401A5 (https=) | ||
| JP2025508052A5 (https=) | ||
| JPH06502619A (ja) | 酵素不活性化剤 | |
| JP2023520703A5 (https=) | ||
| US8987313B2 (en) | Inhibitors of cytochrome P450 | |
| ZA200507007B (en) | Pharmaceutical preparations comprising acid-stabilised insulin | |
| JPH04253914A (ja) | 抗ｈｂｖピリミジンヌクレオシド | |
| JP2024543259A5 (https=) | ||
| JPS6251261B2 (https=) | ||
| JPH11501303A (ja) | Ｂｃｈ−１８９とリトナビールとからなる抗ウイルス剤の組み合わせ |